Aurothioglucose
A gold-containing glucose derivate.
General information
Aurothioglucose is a drug formerly used for rheumatoid arthritis treatment. It contains a sulfhydryl group and a gold cation, which were hypothesized to inhibit adenylyl cyclase in some lymphocyte populations, leading to inhibition of mast cell degranulation, respiratory burst effect enhancement and other pro-inflammatory processes (DrugBank).
Aurothioglucose on PubChem
Aurothioglucose on Wikipedia
Synonyms
Gold thioglucose
Marketed as
RENOL; ORONOL; ROMOSOL; SOLGANAL; SOLGANAL B
C([C@@H]1[C@H]([C@@H]([C@H](C(O1)[S-])O)O)O)O.[Au+]
Supporting references
Link | Tested on | Impact factor | Notes | Publication date |
---|---|---|---|---|
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
3CLpro Enzyme assay In vitro In silico Screening |
in silico; in vitro enzyme assay | 2.74 | Inhibited the SARS-CoV-2 3C-like protease in vitro with IC50 of ca. 13.32 μM. |
Feb/01/2021 |